Study of Upifitamab Rilsodotin in Combination With Carboplatin in Participants With High-grade Serous Ovarian Cancer
Clinical trial NCT04907968 · TERMINATED
Trial details
- NCT number
- NCT04907968
- Sponsor
- Mersana Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-11
- Primary completion
- 2023-10-03
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.